HANMI PHARM. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,17,000 KRW | -0.78% |
|
+2.09% | -10.07% |
| 01/05 | Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% | MT |
| 19/03 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Hanmi Pharm. Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
ba86c8ffb97843bff9.UVvKvGPWhyM3KbEpokRUXhrBa174vof1lTfUBoJqcqU.HQ6bzDv70m1cEd1Q0ygTF06pIwyr7PWN5wW9VdopKNU2DfLOG7zJVAYQ2g~b9fbeaa149e295ce0d3d42f05ac871ac
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
3,17,000
KRW
Average target price
4,08,986
KRW
Spread / Average Target
+29.02%
High Price Target
4,40,000
KRW
Spread / Highest target
+38.80%
Low Price Target
3,27,759
KRW
Spread / Lowest Target
+3.39%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A128940 Stock
- Consensus Hanmi Pharm. Co., Ltd.
